Jamie - AMBS needs revenue - it's just that simple - that's the only thing that will move this security - with 927-Mil. in the float, the churn rate is too high - the Street is also gun shy on taking any positions of significance with a potentially large RS looming. Bobby Farrell and the financial advisors need to address this matter head on
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links